"It Takes a Village – How Teamwork Changed Our Implementation of the ICU Delirium and Mobility Bundle"
ICU Morbidity Clinical Impact Interest Group
Funded by the Gordon and Betty Moore Foundation, the ICU Morbidity Clinical Impact Interest Group (CIIG) addresses two significant, preventable, interconnected causes of morbidity and mortality in ICUs today: delirium and muscle weakness.
Delirium (the acute, fluctuating change in consciousness and cognition that develops over a brief time period) is a frequent complication of critical care and develops in greater than two thirds of critically ill patients. Without active monitoring, delirium goes undiagnosed in up to 72% of cases.
Neuromuscular dysfunction occurs in 46% of critically ill patients. Sedation, delirium, and immobility in ICU patients lead to increased length of stay, increased morbidity and mortality, higher cost of care, and long-term harm including cognitive and functional deficits.
Wes Ely, MD MPH, Vanderbilt University Medical Center
Michele Balas, PhD RN APRN-NP CCRN, University of Nebraska Medical Center
Change BundleBecause ICU acquired weakness and delirium interact with each other and have similar risk factors, an evidence-based treatment bundle has been developed to address both conditions: the ABCDE bundle.
For more information about the ICU Morbidity Clinical Impact Interest Group, please contact Kathleen Carrothers at firstname.lastname@example.org.